Population pharmacokinetic analysis of drug–drug interactions among risperidone, bupropion, and sertraline in CF1 mice

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

Mauricio Tohen, Eduard Vieta, Joseph R. Calabrese et al. · Archives of General Psychiatry · 2003 · 910 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs

Kelly M. Mahar Doan, Joan E. Humphreys, Lindsey O. Webster et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 626 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants

L M Hesse, Karthik Venkatakrishnan, Michael H. Court et al. · Drug Metabolism and Disposition · 2000 · 399 citations

Medicine, Biochemistry, Pharmacology +17

Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man

Jan J.P. Bogaards, Marc Bertrand, Peter F. Jackson et al. · Xenobiotica · 2000 · 366 citations

Life Sciences, Biochemistry, Pharmacology +17

Inhibition of P-Glycoprotein by Newer Antidepressants

Sven-Maria Gregor Dormann, Meret Martin‐Facklam, Christian Johannes Kerpen et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 293 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15